ABOS · Forms 3, 4, 5
Insider trades at Acumen Pharmaceuticals, Inc.
No open-market insider buys or sells at Acumen Pharmaceuticals, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Acumen Pharmaceuticals, Inc. (ABOS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Acumen Pharmaceuticals, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Derrell Porter | Director | Option exercise | 13,040 | $1.07 | $14K | Form 4 | |
| Derrell Porter | Director | Sell | 13,040 | $2.33 | $30K | Form 4 | |
| Derrell Porter | Director | Sell | 12,800 | $2.33 | $30K | Form 4 | |
| Derrell Porter | Director | Option exercise | 6,460 | $1.07 | $7K | Form 4 | |
| Derrell Porter | Director | Sell | 6,460 | $2.35 | $15K | Form 4 | |
| Nathan B Fountain | Director | Sell | 6,400 | $2.23 | $14K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Award | 35,500 | Form 4 | |||
| Nathan B Fountain | Director | Award | 35,500 | Form 4 | |||
| Kimberlee C Drapkin | Director | Award | 35,500 | Form 4 | |||
| John A Stalfort III | Director | Award | 35,500 | Form 4 | |||
| Derrell Porter | Director | Award | 35,500 | Form 4 | |||
| Jeffrey L. Ives | Director | Award | 35,500 | Form 4 | |||
| George Golumbeski | Director | Award | 35,500 | Form 4 | |||
| Laura Stoppel | Director | Award | 35,500 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.